Aer Therapeutics Closes $36 Million Series A Funding Round to Advance Development of an Innovative Mucolytic for the Treatment of Lung Diseases
This item is under embargo and is only visible to journalists
Please login here
Regions: Europe, Ireland
Keywords: Health, Medical, Well being, Science, Life Sciences, Business, Knowledge transfer, Universities & research
Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.
The item has been withdrawn. If you are a journalists please contact the person that posted the item with any questions.